Pretreatment with the inducers rifampicin and phenobarbital alters ivermectin gastrointestinal disposition

The goal of the study was to evaluate the effects of rifampicin (RFP) and phenobarbital (PBT) on the plasma and gastrointestinal disposition kinetics of ivermectin (IVM) subcutaneously administered to Wistar rats. Fifty seven rats were used. Animals in Group I were the noninduced (control) group. Th...

ver descrição completa

Detalhes bibliográficos
Autores: Ballent, Mariana, Lifschitz, Adrian Luis, Virkel, Guillermo Leon, Maté, María Laura, Lanusse, Carlos Edmundo
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2010
País:Argentina
Recursos:Consejo Nacional de Investigaciones Científicas y Técnicas
Repositorio:CONICET Digital (CONICET)
Idioma:inglés
OAI Identifier:oai:ri.conicet.gov.ar:11336/83890
Acesso em linha:http://hdl.handle.net/11336/83890
Access Level:acceso abierto
Palavra-chave:Ivermectin
Disposition
P-Glycoprotein
Inducers
https://purl.org/becyt/ford/4.3
https://purl.org/becyt/ford/4
id AR_e9d50edc8c1fe99d41ecd95ea36d9f84
oai_identifier_str oai:ri.conicet.gov.ar:11336/83890
network_acronym_str AR
network_name_str Argentina
repository_id_str
dc.title.none.fl_str_mv Pretreatment with the inducers rifampicin and phenobarbital alters ivermectin gastrointestinal disposition
title Pretreatment with the inducers rifampicin and phenobarbital alters ivermectin gastrointestinal disposition
spellingShingle Pretreatment with the inducers rifampicin and phenobarbital alters ivermectin gastrointestinal disposition
Ballent, Mariana
Ivermectin
Disposition
P-Glycoprotein
Inducers
https://purl.org/becyt/ford/4.3
https://purl.org/becyt/ford/4
title_short Pretreatment with the inducers rifampicin and phenobarbital alters ivermectin gastrointestinal disposition
title_full Pretreatment with the inducers rifampicin and phenobarbital alters ivermectin gastrointestinal disposition
title_fullStr Pretreatment with the inducers rifampicin and phenobarbital alters ivermectin gastrointestinal disposition
title_full_unstemmed Pretreatment with the inducers rifampicin and phenobarbital alters ivermectin gastrointestinal disposition
title_sort Pretreatment with the inducers rifampicin and phenobarbital alters ivermectin gastrointestinal disposition
dc.creator.none.fl_str_mv Ballent, Mariana
Lifschitz, Adrian Luis
Virkel, Guillermo Leon
Maté, María Laura
Lanusse, Carlos Edmundo
author Ballent, Mariana
author_facet Ballent, Mariana
Lifschitz, Adrian Luis
Virkel, Guillermo Leon
Maté, María Laura
Lanusse, Carlos Edmundo
author_role author
author2 Lifschitz, Adrian Luis
Virkel, Guillermo Leon
Maté, María Laura
Lanusse, Carlos Edmundo
author2_role author
author
author
author
dc.subject.none.fl_str_mv Ivermectin
Disposition
P-Glycoprotein
Inducers
https://purl.org/becyt/ford/4.3
https://purl.org/becyt/ford/4
topic Ivermectin
Disposition
P-Glycoprotein
Inducers
https://purl.org/becyt/ford/4.3
https://purl.org/becyt/ford/4
description The goal of the study was to evaluate the effects of rifampicin (RFP) and phenobarbital (PBT) on the plasma and gastrointestinal disposition kinetics of ivermectin (IVM) subcutaneously administered to Wistar rats. Fifty seven rats were used. Animals in Group I were the noninduced (control) group. Those in Groups II and III received a treatment with RFP (160 mg/day) and PBT (35 mg/day), respectively, both given orally during eight consecutive days as induction regimen. The IVM pharmacokinetic study was started 24 h after the RFP and PBT last administration. Animals received IVM (200 μg/kg) by subcutaneous injection. Rats were sacrificed between 6 h and 3 days after IVM administration. Blood and samples of liver tissue, intestinal wall and luminal content of jejunum were collected from each animal. IVM concentrations were measured by high performance liquid chromatography. IVM disposition kinetics in plasma and tissues was significantly modified by the PBT treatment, but not by RFP. Despite the enhanced CYP3A activity observed after the pretreatment with RPF and PBT, there were no marked changes on the percentages of IVM metabolites recovered from the bloodstream in induced and noninduced animals. An enhanced P-glycoprotein-mediated intestinal transport activity in pretreated animals (particularly in PBT pretreated rats) may explain the drastic changes observed on IVM disposition.
publishDate 2010
dc.date.none.fl_str_mv 2010-07
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/83890
Ballent, Mariana; Lifschitz, Adrian Luis; Virkel, Guillermo Leon; Maté, María Laura; Lanusse, Carlos Edmundo; Pretreatment with the inducers rifampicin and phenobarbital alters ivermectin gastrointestinal disposition; Wiley Blackwell Publishing, Inc; Journal of Veterinary Pharmacology and Therapeutics; 33; 3; 7-2010; 252-259
0140-7783
CONICET Digital
CONICET
url http://hdl.handle.net/11336/83890
identifier_str_mv Ballent, Mariana; Lifschitz, Adrian Luis; Virkel, Guillermo Leon; Maté, María Laura; Lanusse, Carlos Edmundo; Pretreatment with the inducers rifampicin and phenobarbital alters ivermectin gastrointestinal disposition; Wiley Blackwell Publishing, Inc; Journal of Veterinary Pharmacology and Therapeutics; 33; 3; 7-2010; 252-259
0140-7783
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2885.2009.01129.x
info:eu-repo/semantics/altIdentifier/doi/10.1111/j.1365-2885.2009.01129.x
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Wiley Blackwell Publishing, Inc
publisher.none.fl_str_mv Wiley Blackwell Publishing, Inc
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1799196371158302720
spelling Pretreatment with the inducers rifampicin and phenobarbital alters ivermectin gastrointestinal dispositionBallent, MarianaLifschitz, Adrian LuisVirkel, Guillermo LeonMaté, María LauraLanusse, Carlos EdmundoIvermectinDispositionP-GlycoproteinInducershttps://purl.org/becyt/ford/4.3https://purl.org/becyt/ford/4The goal of the study was to evaluate the effects of rifampicin (RFP) and phenobarbital (PBT) on the plasma and gastrointestinal disposition kinetics of ivermectin (IVM) subcutaneously administered to Wistar rats. Fifty seven rats were used. Animals in Group I were the noninduced (control) group. Those in Groups II and III received a treatment with RFP (160 mg/day) and PBT (35 mg/day), respectively, both given orally during eight consecutive days as induction regimen. The IVM pharmacokinetic study was started 24 h after the RFP and PBT last administration. Animals received IVM (200 μg/kg) by subcutaneous injection. Rats were sacrificed between 6 h and 3 days after IVM administration. Blood and samples of liver tissue, intestinal wall and luminal content of jejunum were collected from each animal. IVM concentrations were measured by high performance liquid chromatography. IVM disposition kinetics in plasma and tissues was significantly modified by the PBT treatment, but not by RFP. Despite the enhanced CYP3A activity observed after the pretreatment with RPF and PBT, there were no marked changes on the percentages of IVM metabolites recovered from the bloodstream in induced and noninduced animals. An enhanced P-glycoprotein-mediated intestinal transport activity in pretreated animals (particularly in PBT pretreated rats) may explain the drastic changes observed on IVM disposition.Fil: Ballent, Mariana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Fisiopatología. Laboratorio de Farmacología; ArgentinaFil: Lifschitz, Adrian Luis. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Fisiopatología. Laboratorio de Farmacología; ArgentinaFil: Virkel, Guillermo Leon. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Fisiopatología. Laboratorio de Farmacología; ArgentinaFil: Maté, María Laura. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Fisiopatología. Laboratorio de Farmacología; ArgentinaFil: Lanusse, Carlos Edmundo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Fisiopatología. Laboratorio de Farmacología; ArgentinaWiley Blackwell Publishing, Inc2010-07info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/83890Ballent, Mariana; Lifschitz, Adrian Luis; Virkel, Guillermo Leon; Maté, María Laura; Lanusse, Carlos Edmundo; Pretreatment with the inducers rifampicin and phenobarbital alters ivermectin gastrointestinal disposition; Wiley Blackwell Publishing, Inc; Journal of Veterinary Pharmacology and Therapeutics; 33; 3; 7-2010; 252-2590140-7783CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2885.2009.01129.xinfo:eu-repo/semantics/altIdentifier/doi/10.1111/j.1365-2885.2009.01129.xinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2024-05-08T14:25:11Zoai:ri.conicet.gov.ar:11336/83890instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982024-05-08 14:25:12.12CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
score 15,812429

Registos relacionados